Fundraising Fox
Infinant Health
Sacramento, US · Founded 2011 · Delaware corporation · 8 known investors
Find your way into Infinant Health
Each arrow is one introduction. Sign up to fill in the first one.
Ask Howard Liu to introduce you to David Mills
You →Howard · together at one.bio →David
Ask Jamie Chen to introduce you to James Campbell
You →Jamie · together at Ausbiotech →James
Ask Sam Okafor to introduce you to David J. Kyle
You →Sam · together at Infinant Health →David
Sign up to find every way you can get introduced to Infinant Health
- Your email: who you already know at Infinant Health, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Infinant Health team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants. The company operates in the infant health and microbiome therapeutics space.
Founders & leadership
Board
Investors · 8
How we know: Acre Venture Partners's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: Bow Capital's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: iSelect Fund's portfolio page · Not right? Tell us
How we know: Longitude Capital's portfolio page · Not right? Tell us
How we know: Spruce Capital Partners's portfolio page · board seat on SEC Form D · Not right? Tell us
How we know: Xeraya Capital's portfolio page · Not right? Tell us
How we know: offering press articles · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$48.2M disclosed across 2 rounds · 2015–2026
▶$39.2MraisedJun 2026 · 29 investors · Other Health CareRule 506(b)
- Laura StoppelDirector
- Michael JohnsonExecutive Officer, Director
- Mike LiangDirector
- Amanda Birdsey-BensonDirector
- Roger WyseDirector
- Patrick EnrightDirector
- Katharine KnobilDirector
- Offering amount
- $118.2M
- Amount sold
- $39.2M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9MraisedAug 2015 · 7 investors · BiotechnologyRule 506(b)
- Daniel JanneyDirector
- John CampbellExecutive Officer
- J. Bruce GermanDirector
- James CampbellExecutive Officer
- David MillsExecutive Officer
- Catherine MackeyDirector
- David J. KyleExecutive Officer, Director
- Anne LoDirector
- Simon BarnesDirector
- Offering amount
- $9M
- Amount sold
- $9M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Companies working in the same space as Infinant Health.
Frequently asked questions
- What does Infinant Health do?
- Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants. The company operates in the infant health and microbiome therapeutics space.
- Who founded Infinant Health?
- Infinant Health was founded by David J. Kyle, J. Bruce German, David Mills, Carlito Lebrilla, Daniela Barile, Samara Freeman in 2011.
- Who are Infinant Health's investors?
- Infinant Health's investors include Acre Venture Partners, Bow Capital, Horizons Ventures, iSelect Fund, Longitude Capital, Spruce Capital Partners, Xeraya Capital, Bill & Melinda Gates Foundation.
- How much funding has Infinant Health raised?
- Infinant Health has disclosed $48.2M raised across 2 rounds.
- Where is Infinant Health headquartered?
- Infinant Health is headquartered in Sacramento, US.